Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool May 22, 2006 Stephen D. Simpson	Microtek: Tiny Player, Huge Market Can this minuscule medical company produce greater gains? Investors, take note.
The Motley Fool October 17, 2006 Brian Lawler	See Johnson & Johnson Crawl Earnings growth isn't moving right along because the company has become so big. Investors, take note.
The Motley Fool July 20, 2010 Brian Orelli	Is J&J a Bad News Buy? Another quarter in 2010, another lowered earnings guidance for Johnson & Johnson. At least the year is half over for the health-care giant.
The Motley Fool May 23, 2005 Matt Thurmond	Steris, Disinfect Thyself The medical technology company needs to sterilize its acquisition strategy. As it is now, Steris is not well-positioned to deliver shareholder value.
The Motley Fool October 19, 2005 Stephen D. Simpson	Honeywell May Be on Autopilot Can this huge conglomerate stay ahead of maturing markets? The company is on track to match its long-term record of mid-single-digit growth in annual structural free cash flow, offering no compelling reason to purchase shares today.
The Motley Fool April 19, 2004 W.D. Crotty	3M: Money, Margins, Magnificent Trusty old 3M is no ordinary industrial conglomerate.
The Motley Fool January 24, 2006 Stephen D. Simpson	3M Needs to Get MMMoving New CEO George Buckley seems a bit more interested in engineering and innovation than his predecessor. Should he succeed in leveraging 3M's great base of engineering talent, better future growth is attainable. Investors, take note.
BusinessWeek April 14, 2011 Rachel Layne	GE and Siemens: Less May Mean More (Profits) The medical gear makers see an opportunity for their information technology units as hospitals are pressured to improve efficiency and curb waste
The Motley Fool July 18, 2005 Stephen D. Simpson	Philips Stuck in Neutral The growth outlook for this diversified European company looks pretty feeble. But if Philips can get its growth back on track in the next year or so, the valuations today look somewhat reasonable.
The Motley Fool August 3, 2006 S.J. Caplan	Steris Still a Middling Student Beating expectations by a penny doesn't win the manufacturer of infection control and prevention products any high marks. Investors, take note.
The Motley Fool June 9, 2005 Richard Gibbons	Buying on Margins Profit margins are one useful tool for finding great stock values.
The Motley Fool August 17, 2005 David Meier	The Power of Margins The way you think about margins can give you an investing edge.
The Motley Fool January 10, 2008 Mac Greer	Fool Video: The Future of Baidu and Intuitive Surgical How will Baidu and Intuitive Surgical perform in 2008? Could Google have its eyes on Baidu? Could Johnson & Johnson have its sights on Intuitive Surgical? These questions are discussed in this video.
The Motley Fool July 28, 2005 Mike Cianciolo	Stanley Works Acquires Its Way to Growth The nation's leading toolmaker continues to build solid growth. The company projects full-year earnings of $3.20 to $3.30 per diluted share, which would represent an increase of 12% to 16% over last year's earnings.
The Motley Fool April 15, 2005 W.D. Crotty	GE's Spring Cleaning General Electric continues to downsize its insurance unit, which is a weak spot in an otherwise strong quarter.
The Motley Fool October 13, 2008 Brian Orelli	Foolish Forecast: J&J's Diversity Counts Views you can use to get clues on tomorrow's news
The Motley Fool November 8, 2005 Stephen D. Simpson	Fresh Del Monte's Spotty Results Strong sales, good margins, and higher promotion expenses at the prepared food company highlight this stock's complexity.
The Motley Fool October 16, 2008 Brian Orelli	Foolish Forecast: Robots on the Cheap Intuitive Surgical releases earnings in a few hours. Here are some premonitions to tide you over as you anxiously wait the news.
The Motley Fool October 18, 2005 Stephen D. Simpson	3 Cheers for 3M? Sales and margin improvements underlie the value for investors here.
The Motley Fool April 28, 2005 Mike Cianciolo	Stanley Hammers Away Stanley Works powers ahead with record earnings and sales. Assuming it can improve margins a bit, this stock has a lot to offer investors.
The Motley Fool August 31, 2006	Foolish Fundamentals: Margins Margins are important, but how you use margin information is more important to your investing success. Don't stay on the surface when analyzing margins. Your portfolio will thank you for it later.
The Motley Fool November 28, 2008 Brian Orelli	Bargain Stocks for Black Friday: Intuitive Surgical This is a company that's seen trailing-12-month revenue increase 59% year over year. No matter what you think of high-growth stocks, its 25 P/E is pretty darn cheap.
The Motley Fool October 19, 2011 Brian Orelli	Not the Best Quarter, but... There's little reason to worry about Johnson & Johnson.
The Motley Fool June 4, 2010 Brian Richards	Intuitive Surgical: Strengths, Weaknesses, Opportunities, Threats A look inside the business of the da Vinci robot maker.
The Motley Fool October 21, 2009 Brian Orelli	Slicing and Dicing Intuitive Surgical's Quarter Not the best we've seen, but still solid.
The Motley Fool August 19, 2010 Brian Orelli	Buffett Is Buying J&J. Should You? It depends on your time horizon.
The Motley Fool April 15, 2009 Brian Orelli	Johnson & Johnson Still Withstands Recession While Johnson & Johnson is big, it has proven to be agile during the recession, and this quarter was no different.
The Motley Fool July 20, 2010 Jim Mueller	Buy, Sell, or Hold Intuitive Surgical? Coming into the quarterly earnings, what should investors do regarding Intuitive Surgical? Here's a quick look at some arguments for the three possibilities.
The Motley Fool January 23, 2006 Rich Smith	Foolish Forecast: Does 3M Spell Bingo? With 3M's projected earnings growth of 12% per annum over the next five years, you'd probably want its P/E of 19 and price-to-free cash flow ratio 17 to drop a bit before buying this one.
The Motley Fool April 7, 2010 Alex Dumortier	Is GE a Buy? Taking measure of the conglomerate sector.
The Motley Fool July 19, 2011 Brian Orelli	J&J: Better, but Not Best A decent-looking quarter, but a turnaround could still take awhile.
The Motley Fool January 18, 2005 W.D. Crotty	Really See 3M to Appreciate It A familiar story: Earnings are up, but the stock is down. Is value piling up within the stock?
The Motley Fool May 9, 2007	A Clean Look at Steris: Fool by Numbers The medical products maker released fourth-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool July 18, 2005 Nathan Parmelee	A Giant Question for GE Its diversity and double-digit growth across the board are attractive to investors, but is the price right?
The Motley Fool November 9, 2006	Steady Sales at STERIS: Fool by Numbers The sterilization products maker released second-2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool July 18, 2006 Rich Smith	Foolish Forecast: General Dynamics Forms Ranks The defense contracting powerhouse reports its second-quarter earnings results early tomorrow. Investors, take note.
The Motley Fool July 11, 2006 Anders Bylund	Audiovox More Bark Than Bite The electronics company is delivering on its strategy only in the narrowest sense. Investors may be better off with some of the larger competitors, which have all shown a better ability to manage pricing and margins.
The Motley Fool April 21, 2009 Brian Richards	Wonderful Company, but Is the Price Fair? Intuitive Surgical has one of the simplest -- and prettiest -- business models around. But is 24.6 times earnings -- its current multiple -- a "fair price?"
The Motley Fool October 16, 2009 Mike Pienciak	2 Big Reasons to Sell Kimberly-Clark Inferior profitability and weak sales volumes are two reasons to sell Kimberly-Clark.
The Motley Fool January 26, 2011 David Lee Smith	3M's Tiny Beat Hurts Its Shares While it topped the analysts' forecast, the market found 3M's results less than inspiring.
The Motley Fool July 28, 2011	Steris Earnings Preview Steris will unveil its latest earnings Tuesday.
The Motley Fool February 19, 2004 Selena Maranjian	Health-Care Costs' Slow Rise Health-care costs remain a growing problem for many U.S. employers and their employees.
The Motley Fool July 25, 2007 Billy Fisher	Dueling Fools: Intuitive Surgical Bull For a company consistently growing its sales by 50% and maintaining healthy product margins, it's hard to imagine that this medical device maker's stock has yet met its peak.
The Motley Fool July 14, 2008 Brian Orelli	Foolish Forecast: J&J Trudges Along In advance of earnings analysts wonder if Johnson & Johnson is a recovery story waiting to happen, or still stuck in a rut?
The Motley Fool July 20, 2004 Rick Aristotle Munarriz	Margins of Error Profit margins matter. It's why we can get more excited about a company with rich margins when it grows sales -- we know that much more of the incremental dollar will work its way down to the bottom line unscathed.
The Motley Fool April 21, 2010 Brian Orelli	Yawn! Get Back to Me Next Quarter, J&J There's more stagnant growth from the health-care giant.
The Motley Fool August 4, 2006 Jim Mueller	O'Charley's Mixed on Margins Improvement in restaurant gross margins is offset by worse operating margins and give mixed results to investors.
The Motley Fool January 15, 2010 Brian Orelli	The Odor Lingers at Johnson & Johnson The company has to recall products because of a smelly problem.
The Motley Fool August 17, 2005 W.D. Crotty	HP's Stuck in the Margins Hewlett-Packard's third quarter shows an improvement in operating margins, but there's still room to improve. The stock is leading the New York Stock Exchange's most actives list and is one of the top five percentage gainers for the day.
The Motley Fool October 18, 2005 Nathan Slaughter	Good Teamwork at J&J The health-care giant tops third-quarter estimates on strong sales of medical devices.